BAM
CRL icon

Broyhill Asset Management’s Charles River Laboratories CRL Stock Holding History

Broyhill Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,518
Closed -$2.16M – 78
2026
Q1 		$2.16M Sell
12,518
-2,234
-15% -$414K 2% 17
2025
Q4 		$2.94M Sell
14,752
-36
-0.2% -$6.53K 2.59% 14
2025
Q3 		$2.31M Sell
14,788
-1,547
-9% -$246K 2.03% 18
2025
Q2 		$2.48M Buy
16,335
+3,076
+23% +$410K 2.25% 17
2025
Q1 		$2M Buy
13,259
+325
+3% +$54.5K 1.62% 21
2024
Q4 		$3.16M Buy
+12,934
New +$2.49M 2.78% 12

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Broyhill Asset Management's CRL Position: Q2 2026 in Review

Broyhill Asset Management sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 12,518 shares — an estimated $2.16M sold.

Broyhill Asset Management first reported a position in CRL in Q4 2024 and held it in 6 quarters. The position peaked at $3.16M in Q4 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Broyhill Asset Management reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Broyhill Asset Management sold 12,518 Charles River Laboratories shares in Q2 2026, an estimated $2.16M.
  • Broyhill Asset Management first reported a position in Charles River Laboratories in Q4 2024 and held it in 6 quarters.
  • Broyhill Asset Management's Charles River Laboratories position peaked at $3.16M in Q4 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Broyhill Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.